4//SEC Filing
Xynos Konstantinos 4
Accession 0001104659-24-043256
CIK 0001737953other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 8:02 PM ET
Size
7.6 KB
Accession
0001104659-24-043256
Insider Transaction Report
Form 4
Xynos Konstantinos
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-04-01+80,000→ 80,000 totalExercise: $7.73Exp: 2034-04-01→ Common Stock (80,000 underlying) - Award
Common Stock
2024-04-01+26,665→ 139,379 total
Footnotes (2)
- [F1]Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2025 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2028, subject to the Reporting Person's continuous service to the Issuer.
- [F2]25% of the shares underlying this stock option vest on April 1, 2025, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.
Documents
Issuer
Replimune Group, Inc.
CIK 0001737953
Entity typeother
Related Parties
1- filerCIK 0001956241
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 8:02 PM ET
- Size
- 7.6 KB